A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma
Completed · Phase 2
Conditions studied: Relapsed/Refractory Follicular Non-Hodgkin Lymphoma
In brief
This clinical study examined the safety and efficacy of the combination of zanubrutinib and obinutuzumab versus obinutuzumab alone in adults with follicular lymphoma whose disease returned after or did not respond to prior therapy.
Key facts
- Study ID
- NCT03332017
- Run by
- BeiGene
- People needed
- 217
- Starts
- 2017-11-14
- Expected to finish
- 2024-12-27
- Last updated by the study team
- 2026-02-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Illinois At Chicago — Chicago, Illinois, United States
- Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada, United States
- Duke University — Durham, North Carolina, United States
- Canberra Hospital — Garran, Australian Capital Territory, Australia
- Concord Repatriation General Hospital — Concord, New South Wales, Australia
- Saint Vincents Hospital Sydney — Darlinghurst, New South Wales, Australia
- Calvary Mater Newcastle — Waratah, New South Wales, Australia
- Westmead Hospital — Westmead, New South Wales, Australia
- Icon Cancer Centre Wesley — Auchenflower, Queensland, Australia
- Icon Cancer Foundation — South Brisbane, Queensland, Australia
- Royal Adelaide Hospital — Adelaide, South Australia, Australia
- Monash Health — Clayton, Victoria, Australia
- St Vincents Hospital Melbourne — Fitzroy, Victoria, Australia
- Peninsula Private Hospital — Frankston, Victoria, Australia
- Royal Perth Hospital — Perth, Western Australia, Australia
- Minsk City Clinical Oncological Dispensary — Minsk, Belarus
- Nn Alexandrov National Cancer Centre of Belarus — Minsk, Belarus
- Vitebsk Regional Clinical Oncology Dispensary — Vitebsk, Belarus
- University Multiprofile Hospital For Active Treatment Dr Georgi Stranski — Pleven, Bulgaria
- Acibadem City Clinic Mhat Tokuda Ead — Sofia, Bulgaria
- University Multiprofile Hospital For Active Treatment Saint Ivan Rilski — Sofia, Bulgaria
- University Multiprofile Hospital For Active Treatment Alexandrovska — Sofia, Bulgaria
- The Ottawa Hospital — Ottawa, Ontario, Canada
- Jewish General Hospital — Montreal, Quebec, Canada
- Emory University Winship Cancer Institute — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.